Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Agaricus and Reduced Alanine Aminotransferase Level

Doses used in studies

mg/day: 1,500 (median 1,500, IQR 1,500–1,500) — 1 study

Time to effect

Median: 12.2 months · IQR 12.2 months–12.2 months · Range 12.2 months–12.2 months — Reported in 1 of 1 study

1 of 1 paper

The mushroom Agaricus blazei Murill extract normalizes liver function in patients with chronic hepatitis B.
- 2008-04
- Clinical Trial
- Journal of alternative and complementary medicine (New York, N.Y.) 14(3)
- - Chung-Hua Hsu
  - Kung-Chang Hwang
  - Yi-Hsiung Chiang
  - Pesus Chou
- PubMed: 18370584
- DOI: 10.1089/acm.2006.6344
2 Insights on
- Reduced Alanine Aminotransferase Level
- Moderate evidence
- Clinical
alanine aminotransferase decreased from 151.0 (+/- SD 86.9) to 46.1 (+/- SD 22.5) IU/L
Effect
Neutral
Effect size
Small
Significant
No
Dose
1500 mg daily